⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 1998Nephrology Dialysis Transplantation

Seminal contribution to dialysis. Daily-dialysis programme: indications and results

V. Bonomini V. Mioli A Albertazzi P. Scolari

View at Publisher

Ask AI

Bookmark

Share

Abstract

V Bonomini, V Mioli, A Albertazzi, P Scolari; Daily-dialysis programme: indications and results., Nephrology Dialysis Transplantation, Volume 13, Issue 11,

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bonomini et al. (1998) studied this question.

synapsesocial.com/papers/6a9b021c48c39de7a891e077 https://doi.org/10.1093/ndt/13.11.2774

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Per-protocol repeat kidney biopsy in lupus nephritis: one more branch of the treeNephrology Dialysis Transplantation · Wed,
2Trends in nephrology: tolerance induction through hematopoietic chimerism in kidney transplantationNephrology Dialysis Transplantation · Wed,
3The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline CharacteristicsNephrology Dialysis Transplantation · Wed,
4C5 Inhibition for Anti-Cancer Therapy-Induced Renal Thrombotic MicroangiopathyNephrology Dialysis Transplantation · Wed,
5Recombinant shingles vaccination and the risk of cardiovascular events: association or causation?Nephrology Dialysis Transplantation · Mon,

More from Nephrology Dialysis Transplantation

From Stone Removal to Disease Management: Do the 2026 EAU Guidelines Call for a New Urology–Nephrology Partnership?Mon,
High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide studyFri,
Long forms of cardiac troponin T are independent of kidney function and improve the diagnosis of myocardial infarctionFri,
Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic StrategiesFri,
Anti-CD38 monoclonal antibodies in kidney disease: mechanistic rationale and emerging clinical evidenceThu,